Narcolepsy News

Narcolepsy Therapeutics Market - Analysis, Trends & Forecasts to 2025 - Research and Markets - Business Wire (press release)



Invest Daily News: Market Research News by Market.Biz (press release)
 
Narcolepsy Therapeutics Market - Analysis, Trends & Forecasts to 2025 - Research and Markets 
Business Wire (press release)
The global narcolepsy therapeutics market is expected to reach USD 3.85 billion by 2025. The increasing awareness about this sleep disorder among public and healthcare providers is a key factor contributing to the market growth. The Narcolepsy Network ...
Narcolepsy Drugs Market by 2022 Analysis, Market Dynamics, Regions, Consumption, Production, Suppliers and ... MilTech
Europe Narcolepsy Drug Market Teva Pharmaceutical, Jazz ... Invest Daily News: Market Research News by Market.Biz (press release)
Narcolepsy Drugs Market in United States 2017 Trends ... Newshawk Time (blog)

all 5 news articles » 


Narcolepsy - Pipeline Review, H2 2017 - PR Newswire (press release)



Narcolepsy - Pipeline Review, H2 2017 
PR Newswire (press release)
Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime sleepiness (EDS), cataplexy, hallucinations and sleep paralysis. Narcolepsy treatment includes ...
Narcolepsy - Pipeline Review, H2 2017 | Markets Insider Markets Insider

all 19 news articles » 


Newly formed Montco biopharm firm raises $270M - Philadelphia Business Journal



Philadelphia Business Journal
 
Newly formed Montco biopharm firm raises $270M 
Philadelphia Business Journal
A Montgomery County biopharmaceutical company has raised $270 million, completing the largest equity financing in the local life sciences sector this year, while also acquiring U.S. rights to a narcolepsy drug from a French company. Harmony Biosciences ...
Harmony Biosciences Acquires US Rights to Pitolisant From ... PR Newswire (press release)
Harmony Biosciences gains US rights to pitolisant; raises $270 million The Pharma Letter

all 3 news articles » 


H2 Narcolepsy Market Pipeline Review 2017 Trend Analysis Report ... - Medgadget (blog)



Medgadget (blog)
 
H2 Narcolepsy Market Pipeline Review 2017 Trend Analysis Report ... 
Medgadget (blog)
Description: The Global Narcolepsy report has been prepared keeping in mind the need of the customers for the latest information in the Narcolepsy. With th.

and more » 


Narcolepsy Drug Molecule Type, Sleep Disorder Treatment, Symptoms & Therapeutic Development - Medgadget (blog)



Medgadget (blog)
 
Narcolepsy Drug Molecule Type, Sleep Disorder Treatment, Symptoms & Therapeutic Development 
Medgadget (blog)
A new research document with title 'Narcolepsy ? Pipeline Review, H2 2017'covering detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions like North America, China, Europe ...

and more » 


Harmony Biosciences Acquires US Rights to Narcolepsy Drug That Is Currently Available in Europe - Sleep Review



Harmony Biosciences Acquires US Rights to Narcolepsy Drug That Is Currently Available in Europe 
Sleep Review
The drug is approved in the European Union (EU) and distributed under the tradename WAKIX for the treatment of narcolepsy in adult patients with and without cataplexy. Currently no H3-receptor antagonist/inverse agonist has been approved by the US ...

 


Narcolepsy H2 Pipeline Review market 2017 Analysis Research Report - Medgadget (blog)



Narcolepsy H2 Pipeline Review market 2017 Analysis Research Report 
Medgadget (blog)
Latest Pharmaceutical and Healthcare disease pipeline guide Narcolepsy ? Pipeline Review, H2 2017, provides an overview of the Narcolepsy (Central Nervous System) pipeline landscape. Narcolepsy is a sleep disorder that causes excessive sleepiness ...

and more » 


Narcolepsy Medications: Study Hints at Who Takes What and Why - Sleep Review



Sleep Review
 
Narcolepsy Medications: Study Hints at Who Takes What and Why 
Sleep Review
Factors including gender, geographic region, employment status, and choice of accompanying medication play a role in determining a narcolepsy patient's medication usage. This is according to an abstract published in the journal Sleep and presented at ...

 


Narcolepsy Link Raised Fears that Swine Flu Vaccine Might Up Risks for Other Autoimmune Diseases But Study Finds ... - Sleep Review



Narcolepsy Link Raised Fears that Swine Flu Vaccine Might Up Risks for Other Autoimmune Diseases But Study Finds ... 
Sleep Review
There has been a fear that the swine flu vaccine, Pandemrix, would increase the risk of autoimmune diseases other than narcolepsy. However, a new study of children from Sweden and Finland shows that the vaccine increased neither the risk of developing ...

 


Theranexus Gets US Patent Covering Drug Candidate THN102 for Narcolepsy, Parkinson's - Sleep Review



Theranexus Gets US Patent Covering Drug Candidate THN102 for Narcolepsy, Parkinson's 
Sleep Review
This drug candidate is currently in a phase II clinical trial in patients with narcolepsy. In parallel with narcolepsy, we are going to start a new phase II clinical trial in patients with Parkinson's disease who suffer from excessive daytime ...